202 related articles for article (PubMed ID: 28741298)
21. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
[TBL] [Abstract][Full Text] [Related]
22. The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C.
Keshvari M; Alavian SM; Behnava B; Pouryasin A; Sharafi H
J Res Med Sci; 2016; 21():72. PubMed ID: 27904617
[TBL] [Abstract][Full Text] [Related]
23. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
Bharatiya S; Agarwal A; Chinnaswamy S
J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
[TBL] [Abstract][Full Text] [Related]
24. Association between IFNL4 rs368234815 polymorphism and sustained virological response in chronic hepatitis C patients undergoing PEGylated interferon/ribavirin therapy: A meta-analysis.
Xie X; Zhang L; Chen YZ
Hum Immunol; 2016 Jul; 77(7):609-15. PubMed ID: 27180197
[TBL] [Abstract][Full Text] [Related]
25. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.
Milano M; Aghemo A; Mancina RM; Fischer J; Dongiovanni P; De Nicola S; Fracanzani AL; D'Ambrosio R; Maggioni M; De Francesco R; Fargion S; Berg T; Stickel F; Hampe J; Romeo S; Colombo M; Valenti L
Hepatology; 2015 Jul; 62(1):111-7. PubMed ID: 25820484
[TBL] [Abstract][Full Text] [Related]
26. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
[TBL] [Abstract][Full Text] [Related]
27. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
28. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
[TBL] [Abstract][Full Text] [Related]
29. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
Eslam M; Hashem AM; Leung R; Romero-Gomez M; Berg T; Dore GJ; Chan HL; Irving WL; Sheridan D; Abate ML; Adams LA; Mangia A; Weltman M; Bugianesi E; Spengler U; Shaker O; Fischer J; Mollison L; Cheng W; Powell E; Nattermann J; Riordan S; McLeod D; Armstrong NJ; Douglas MW; Liddle C; Booth DR; George J; Ahlenstiel G;
Nat Commun; 2015 Mar; 6():6422. PubMed ID: 25740255
[TBL] [Abstract][Full Text] [Related]
30. IFNL4: Notable variants and associated phenotypes
Fang MZ; Jackson SS; O'Brien TR
Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
[TBL] [Abstract][Full Text] [Related]
31. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
Aiken T; Garber A; Thomas D; Hamon N; Lopez R; Konjeti R; McCullough A; Zein N; Fung J; Askar M; John BV
PLoS One; 2016; 11(11):e0166998. PubMed ID: 27875564
[TBL] [Abstract][Full Text] [Related]
32. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
[TBL] [Abstract][Full Text] [Related]
33. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.
Valenti L; Motta BM; Alisi A; Sartorelli R; Buonaiuto G; Dongiovanni P; Rametta R; Pelusi S; Fargion S; Nobili V
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):588-93. PubMed ID: 22157924
[TBL] [Abstract][Full Text] [Related]
34. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
Lu YF; Goldstein DB; Urban TJ; Bradrick SS
Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
[TBL] [Abstract][Full Text] [Related]
35. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
[TBL] [Abstract][Full Text] [Related]
36. IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.
Real LM; Herrero R; Rivero-Juárez A; Camacho Á; Macías J; Vic S; Soriano V; Viedma S; Guardiola JM; Fibla J; Rivero A; Pineda JA; Caruz A
AIDS; 2015 Sep; 29(14):1895-7. PubMed ID: 26372394
[TBL] [Abstract][Full Text] [Related]
37. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
[TBL] [Abstract][Full Text] [Related]
38. High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815.
Galmozzi E; Facchetti F; Perbellini R; Aghemo A
Clin Microbiol Infect; 2014 Nov; 20(11):O936-8. PubMed ID: 24724563
[TBL] [Abstract][Full Text] [Related]
39. Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
Støy S; Terczynska-Dyla E; Veidal SS; Rigbolt K; Vilstrup H; Grønbaek H; Hartmann R; Sandahl TD
Scand J Gastroenterol; 2021 Mar; 56(3):304-311. PubMed ID: 33602032
[TBL] [Abstract][Full Text] [Related]
40. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
Noureddin M; Rotman Y; Zhang F; Park H; Rehermann B; Thomas E; Liang TJ
Genes Immun; 2015; 16(5):321-9. PubMed ID: 26020282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
